XML 123 R103.htm IDEA: XBRL DOCUMENT v3.19.1
Supplemental Condensed Consolidating Financial Information (Schedule of Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net cash (used in) provided by operating activities $ 133 $ 106
Cash flows from investing activities:    
Acquisitions of facilities and other related businesses (4) (8)
Purchases of property and equipment (121) (170)
Proceeds from disposition of hospitals and other ancillary operations 161 11
Proceeds from sale of property and equipment   3
Purchases of available-for-sale securities and equity securities (15) (19)
Proceeds from sales of available-for-sale securities and equity securities 32 34
Increase in other investments (34) (28)
Net cash provided by (used in) investing activities 19 (177)
Cash flows from financing activities:    
Repurchase of restricted stock shares for payroll tax withholding requirements (1) (1)
Deferred financing costs and other debt-related costs (25) (11)
Proceeds from noncontrolling investors in joint ventures 1  
Redemption of noncontrolling investments in joint ventures (1) (3)
Distributions to noncontrolling investors in joint ventures (27) (23)
Borrowings under credit agreements 12 10
Issuance of long-term debt 1,840  
Proceeds from ABL facility 25 49
Repayments of long-term indebtedness (1,895) (89)
Net cash used in financing activities (71) (68)
Net change in cash and cash equivalents 81 (139)
Cash and cash equivalents at beginning of period 196 563
Cash and cash equivalents at end of period 277 424
Parent Guarantor [Member]    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities   26
Cash flows from financing activities:    
Repurchase of restricted stock shares for payroll tax withholding requirements (1) (1)
Changes in intercompany balances with affiliates, net 1 (25)
Net cash used in financing activities   (26)
Issuer [Member]    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities (59) (58)
Cash flows from investing activities:    
Proceeds from disposition of hospitals and other ancillary operations 18  
Net cash provided by (used in) investing activities 18  
Cash flows from financing activities:    
Deferred financing costs and other debt-related costs (25)  
Changes in intercompany balances with affiliates, net 83 69
Issuance of long-term debt 1,840  
Proceeds from ABL facility 25  
Repayments of long-term indebtedness (1,882) (11)
Net cash used in financing activities 41 58
Other Guarantor [Member]    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities 130 108
Cash flows from investing activities:    
Acquisitions of facilities and other related businesses (3) (3)
Purchases of property and equipment (102) (119)
Proceeds from disposition of hospitals and other ancillary operations 138 10
Proceeds from sale of property and equipment   1
Purchases of available-for-sale securities and equity securities (9) (11)
Proceeds from sales of available-for-sale securities and equity securities 20 28
Increase in other investments (32) (14)
Net cash provided by (used in) investing activities 12 (108)
Cash flows from financing activities:    
Deferred financing costs and other debt-related costs   (11)
Changes in intercompany balances with affiliates, net (62) (136)
Borrowings under credit agreements 12 10
Proceeds from ABL facility   49
Repayments of long-term indebtedness (10) (76)
Net cash used in financing activities (60) (164)
Net change in cash and cash equivalents 82 (164)
Cash and cash equivalents at beginning of period 135 499
Cash and cash equivalents at end of period 217 335
Non-Guarantor Subsidiaries [Member]    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities 62 30
Cash flows from investing activities:    
Acquisitions of facilities and other related businesses (1) (5)
Purchases of property and equipment (19) (51)
Proceeds from disposition of hospitals and other ancillary operations 5 1
Proceeds from sale of property and equipment   2
Purchases of available-for-sale securities and equity securities (6) (8)
Proceeds from sales of available-for-sale securities and equity securities 12 6
Increase in other investments (2) (14)
Net cash provided by (used in) investing activities (11) (69)
Cash flows from financing activities:    
Proceeds from noncontrolling investors in joint ventures 1  
Redemption of noncontrolling investments in joint ventures (1) (3)
Distributions to noncontrolling investors in joint ventures (27) (23)
Changes in intercompany balances with affiliates, net (22) 92
Repayments of long-term indebtedness (3) (2)
Net cash used in financing activities (52) 64
Net change in cash and cash equivalents (1) 25
Cash and cash equivalents at beginning of period 61 64
Cash and cash equivalents at end of period $ 60 $ 89